These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15008167)

  • 1. Grassroots lobbying: an important tool for pharmacy. Lobbying can lead to acknowledgment as health care providers.
    Lipowski E
    J Am Pharm Assoc (2003); 2004; 44(1):6-7. PubMed ID: 15008167
    [No Abstract]   [Full Text] [Related]  

  • 2. Grassroots lobbying: an important tool for pharmacy. Developing grassroots advocate.
    Boyle C
    J Am Pharm Assoc (2003); 2004; 44(1):5-6. PubMed ID: 14965144
    [No Abstract]   [Full Text] [Related]  

  • 3. Grassroots lobbying: an important tool for pharmacy. Lobbying begins in pharmacy school.
    Kim T
    J Am Pharm Assoc (2003); 2004; 44(1):8-9. PubMed ID: 15008170
    [No Abstract]   [Full Text] [Related]  

  • 4. Affiliated state chapter experience with a professional lobbyist for pharmacy legislative activities.
    Voytovich RM; Esposito SL; Erdos R
    Am J Hosp Pharm; 1988 Apr; 45(4):827-31. PubMed ID: 3376966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a grassroots advocacy movement through state and local collaboration.
    Berger K; Kaplan AS
    Am J Health Syst Pharm; 2019 May; 76(11):774-778. PubMed ID: 30989190
    [No Abstract]   [Full Text] [Related]  

  • 6. Why should you be a member, you ask? (Hint: It isn't always about the CE.).
    Sinnett MJ
    J Pharm Pract; 2012 Oct; 25(5):561-2. PubMed ID: 23011964
    [No Abstract]   [Full Text] [Related]  

  • 7. CHA supports system grassroots advocacy efforts.
    Place MD
    Health Prog; 1998; 79(6):10-1. PubMed ID: 10339220
    [No Abstract]   [Full Text] [Related]  

  • 8. Igniting the fire within: a primer on political advocacy for pharmacy professionals.
    Gohlke AL; Murphy KM; Cannell ME; Ray DB; Burnworth MJ
    J Pharm Pract; 2013 Jun; 26(3):165-70. PubMed ID: 23553545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APhA2009 House of Delegates: serving the association and the profession.
    Weitzel KW; Tisdale JE; Mattingly J
    J Am Pharm Assoc (2003); 2009; 49(4):474-80. PubMed ID: 19589755
    [No Abstract]   [Full Text] [Related]  

  • 10. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 11. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 12. National health care reform, Part 2: Response to pharmacists.
    Zellmer WA
    Am J Hosp Pharm; 1994 Dec; 51(24):3096. PubMed ID: 7856635
    [No Abstract]   [Full Text] [Related]  

  • 13. The shaping of health care policy.
    Gottlieb KC
    Manag Care; 2002 Jul; 11(7 Suppl):4-7; discussion 7. PubMed ID: 12181874
    [No Abstract]   [Full Text] [Related]  

  • 14. Government Affairs--1985: effective strategies, effective campaigns.
    Murphy DH
    Am Pharm; 1986 Jan; NS26(1):22-3, 26-7. PubMed ID: 3953415
    [No Abstract]   [Full Text] [Related]  

  • 15. Nurses and public policy.
    Nault DS
    Mich Nurse; 2012; 85(1):13-20; quiz 21-2. PubMed ID: 22375353
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiply your clout with a grassroots lobbying network.
    Walters J
    Assoc Manage; 1983 Apr; 35(4):56-61. PubMed ID: 10259353
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care.
    Kim HJ; Chung W; Lee SG
    Health Policy; 2004 Jun; 68(3):267-75. PubMed ID: 15113638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy, politics, and public policy.
    Coster JM
    Am J Hosp Pharm; 1992 Jul; 49(7):1759-62. PubMed ID: 1621736
    [No Abstract]   [Full Text] [Related]  

  • 20. ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.
    Meyer GE; Keith TD; Gutfeld MB; Johnson D
    Am J Hosp Pharm; 1994 Feb; 51(4):520-1. PubMed ID: 8017422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.